Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Greenberg

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Blood|October 18, 2007
Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experienceSophie Park, Sophie Grabar, Charikleia Kelaidi, et al.
The Lancet. Oncology|March 13, 2016
Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trialGuillermo Garcia-Manero, Pierre Fenaux, Aref Al-Kali, et al.
Angewandte Chemie (International Ed. in English)|February 4, 2020
A Glycosylated Cationic Block Poly(β-peptide) Reverses Intrinsic Antibiotic Resistance in All ESKAPE Gram-Negative BacteriaZhangyong Si, Hui Wen Lim, Moon Y F Tay, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
Designer broad-spectrum polyimidazolium antibioticsWenbin Zhong, Zhenyu Shi, Surendra H Mahadevegowda, et al.
Advances in Microbial Physiology|November 27, 2021
The Pseudomonas aeruginosa whole genome sequence: A 20th anniversary celebrationFiona S L Brinkman, Geoffrey L Winsor, Rachel E Done, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database mergeJulie Schanz, Heinz Tüchler, Francesc Solé, et al.
Blood|March 25, 2004
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcomeCorey S Cutler, Stephanie J Lee, Peter Greenberg, et al.
Blood Advances|October 9, 2020
Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentationsSimone Feurstein, Ayodeji Adegunsoye, Danijela Mojsilovic, et al.
The Lancet. Haematology|December 22, 2015
Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trialUwe Platzbecker, Raymond S M Wong, Amit Verma, et al.
European Journal of Haematology|November 22, 2007
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective studyJohn Porter, Renzo Galanello, Giuseppe Saglio, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Blood|October 18, 2007
Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experienceSophie Park, Sophie Grabar, Charikleia Kelaidi, et al.
The Lancet. Oncology|March 13, 2016
Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trialGuillermo Garcia-Manero, Pierre Fenaux, Aref Al-Kali, et al.
Angewandte Chemie (International Ed. in English)|February 4, 2020
A Glycosylated Cationic Block Poly(β-peptide) Reverses Intrinsic Antibiotic Resistance in All ESKAPE Gram-Negative BacteriaZhangyong Si, Hui Wen Lim, Moon Y F Tay, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
Designer broad-spectrum polyimidazolium antibioticsWenbin Zhong, Zhenyu Shi, Surendra H Mahadevegowda, et al.
Advances in Microbial Physiology|November 27, 2021
The Pseudomonas aeruginosa whole genome sequence: A 20th anniversary celebrationFiona S L Brinkman, Geoffrey L Winsor, Rachel E Done, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database mergeJulie Schanz, Heinz Tüchler, Francesc Solé, et al.
Blood|March 25, 2004
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcomeCorey S Cutler, Stephanie J Lee, Peter Greenberg, et al.
Blood Advances|October 9, 2020
Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentationsSimone Feurstein, Ayodeji Adegunsoye, Danijela Mojsilovic, et al.
The Lancet. Haematology|December 22, 2015
Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trialUwe Platzbecker, Raymond S M Wong, Amit Verma, et al.
European Journal of Haematology|November 22, 2007
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective studyJohn Porter, Renzo Galanello, Giuseppe Saglio, et al.
Pageof 16